Biology subjects

Kriukov, E.

Publications and source records attributed to Kriukov, E..

9 recordsLinked to original sources

bioRxiv2026

Quantitative assessment of cell fate commitment in single-cell transcriptomics using scCS

Cell fate trajectory inference is one of the key downstream methods in single-cell RNA-sequencing data analysis. Multiple existing tools allow studying such and help identify continuous cell fate dynamics, important genes along the trajectory, and reconstruct the transcriptional states a cell passes to its estimated final state. These methods have been essential to study various biological systems, yet cell fate by itself currently presents mostly qualitative analysis, and existing tools do not allow to directly quantify the fate-related parameters, including commitment, transition speed, fate affinity and entropy. Such quantifications may be performed through multiple parameters and result in better understanding and description of cell fates. We present scCS (single-cell Commitment Scoring), a scverse-friendly Python framework for this problem. scCS introduces Discounted Future-Fate Propagation (DFFP), which models the source transition graph as a geometrically stopped random walk that can reach endpoint anchors or stop unresolved, with a user-defined finite expected graph horizon. For each cell, the resulting probabilities are separated into total fate reach, relative affinity among reached fates, entropy-based fate specificity and reach-supported resolved commitment, while Signed Ordering Flux independently quantifies local progression. scCS also provides endpoint-anchor, graph-coverage and horizon-sensitivity diagnostics, an instantaneous local-direction mode, standardized visualizations, gene-level analyses and replicate-aware comparisons across experimental conditions. Applications to pancreatic endocrinogenesis and neural crest-Schwann-cell differentiation illustrate the general framework. scCS converts an explicit biological fate hypothesis into auditable cell-, population- and replicate-level quantities without redefining the source dynamics.

bioinformatics↗

bioRxiv2025

Quantitative Multicolored Deep Imaging of Human Bones Reveals a Composite Osteo-Sinusoidal Niche for Mesenchymal Stromal Cells.

Human bone marrow mesenchymal stromal/stem cells (BM-MSCs) are widely utilized in clinical trials and tissue engineering; however, their native microenvironment remains poorly understood. Here, we introduced a tissue-clearing protocol for human bones and integrated it with simultaneous mRNA and protein detection. Using this protocol, named DeepBone, we spatially mapped BM-MSCs relative to key bone microenvironment components, including human blood capillaries, adipocytes, sinusoids, and bony trabeculae. Quantitative analysis revealed that the native microenvironment of human BM-MSCs in young bone is enriched in vasculature, sinusoids, bone matrix, and adipocytes. In contrast, in aged bone, BM-MSCs showed no preferential association with bone or adipocytes. Proliferative BM-MSCs were predominantly found along blood vessels. Moreover, we identified a specialized microenvironment for BM-MCs in young bone, characterized by sinusoids coiled around trabeculae and enriched by R-type vessels. These findings provide novel insights into the native niches of BM-MSCs, offering a foundation for the development of tissue-engineering strategies that mimic their physiological context.

cell biology↗

bioRxiv2025

Human retinal organoid single-cell atlas allows to reconstruct retinal development at high resolution and identify nature restricted transcriptional states in vitro

The vertebrate retina is a highly specialized neural structure crucial for the initial capture and processing of visual information. Perturbations in retinal development contribute significantly to congenital and acquired forms of blindness, underscoring the necessity of elucidating human retinal ontogeny. Human pluripotent stem cell-derived retinal organoids have emerged as a powerful model capable of self-organizing and recapitulating key aspects of retinal morphogenesis, offering valuable insights into retinal development and disease. Despite their utility, the extensive cellular heterogeneity, dynamic state transitions, and existence of unique, the development of this system has not yet been fully resolved, posing significant challenges for interpreting their developmental fidelity and therapeutic applicability. Here, we present the Human Retinal Organoid Cell Atlas (HROCA), a comprehensive single-cell transcriptomic reference spanning retinal organoid development from Day 10 to Day 365, integrating data from 15 studies, 71 batches, and encompassing 458,309 cells. HROCA provides a detailed benchmark for organoid differentiation, identifying known retinal cell classes and novel cellular states at single-cell resolution. By associating HROCA with the human fetal retina atlas (HFR), we offer an in-depth comparison between in vitro and in vivo retinal development, revealing protocol-specific differences, limitations in neuronal maturation, and developmental timing discrepancies. HROCA expands our understanding of retinal developmental plasticity, highlighting unique cell populations such as chimeric, non-canonical, and apatride cells, which do not conform to classical retinal cell types but exist consistently across developmental timelines in vitro. This atlas serves as a crucial resource for understanding retinal development, evaluating organoid models, and guiding future improvements in regenerative medicine strategies.

developmental biology↗

bioRxiv2025

Mechanism of PMC (2,2,5,7,8-pentamethyl-6-chromanol), a sterically hindered phenol antioxidant, in rescuing oxidized low-density lipoprotein-induced cytotoxicity in human retinal pigment epithelial cells

Geographic atrophy or late stage dry age-related macular degeneration (AMD) is characterized by drusen deposition and progressive retinal pigment epithelium (RPE) degeneration, leading to irreversible vision loss. The formation of drusen leads to dyshomeostasis, oxidative stress and irreversible damage to RPE. In this study, we used an in vitro model of oxidized-low density lipoproteins (ox-LDL) induced human RPE damage/death model to investigate the mechanism whereby a sterically hindered phenol antioxidant compound, PMC (2,2,5,7,8-pentamethyl-6-chromanol) protects RPE against ox-LDL-induced damage. We show that PMC exerts its protective effect by preventing the upregulation of stress-responsive heme oxygenase-1 (HMOX1/HO-1) and NAD(P)H:quinone oxidoreductase (NQO1) at mRNA and protein levels. This effect was due to PMCs blockade of ROS generation, which in turn blocked nuclear translocation of the Nuclear factor erythroid 2-related factor 2 (Nrf2) transcription factor, ultimately preventing the upregulation of antioxidant response elements (ARE), including HMOX1 and NQO1. A key role for HO-1 was demonstrated when the protective effect of PMC was inhibited by the knockdown of HMOX1. Additionally, treatment of PMC under different experimental conditions and time points revealed that the continuous presence of PMC is required for optimal protection against ox-LDL-induced cytotoxicity, defining the cellular pharmacokinetics of the molecule. Our data demonstrate the involvement of a key antioxidant pathway through which PMC mitigates oxidative stress induced by ox-LDL and provides a potential therapeutic strategy to suppress RPE degeneration/damage during AMD progression.

molecular biology↗

bioRxiv2025

Single-cell transcriptome of retinal myeloid cells in response to transplantation of human neurons reveals reversibility of microglial activation

The host retinal microglia and macrophage activation remains a major challenge for the integration of donor neurons following transplantation. Previously, we and others have shown that it is possible to increase donor retinal ganglion cell (RGC) survival by inhibiting the microglia-RGC interaction with Annexin V or through reprogramming microglia with the soluble Fas ligand. However, the exact mechanisms of the microglia/macrophage activation and their heterogeneity following transplantation remain unknown. To address this question, the donor RGC were differentiated from Brn3b-Tdtomato-Thy1.2 human embryonic stem cells using a 3D protocol, followed by dissociation and RGC purification. RGC were delivered subretinally (1.5x104 viable cells/eye) into 3-6-month-old CX3CR1GFPknock-in mice. Three days after transplantation retinas were dissociated into single-cell suspension and GFP-positive myeloid cells isolated using FACS. Of the sorted cells, up to 10,000 viable cells per sample were used for single-cell RNA library preparation and sequenced using the 10X Genomics Chromium platform. In addition, several retinas were fixed and stained for donor RGC (mCherry) and host microglia/macrophages (Iba1). RNA Velocity was used to reconstruct the myeloid cell population and activation trajectory from scRNAseq data. We observed continuous bi-directional transition of microglia/macrophages from a homeostatic to an activated state. We also observed that the response to the transplant falls into the classic disease-associated-microglia (DAM) activation paradigm with a decrease in expression of the homeostatic gene Tmem119 and an increase in expression of disease-associated genes including Apoe, Lgals3, and Spp1. Our findings show that the host retinal myeloid cell population undergoes activation upon transplantation of stem-cell derived donor RGC, with a molecular profile of the activated cells similar to that of activated myeloid cells associated with neurodegenerative diseases of the brain and the eye. Advanced integrated transcriptomic analysis shows separate activated-to-homeostatic and homeostatic-to-activated trajectories suggesting the reversibility of this process.

neuroscience↗

bioRxiv2024

Unraveling the developmental heterogeneity within the human retina to reconstruct the continuity of retinal ganglion cell maturation and stage-specific intrinsic and extrinsic factors

Tissue development is a complex spatiotemporal process with multiple interdependent components. Anatomical, histological, sequencing, and evolutional strategies can be used to profile and explain tissue development from different perspectives. The introduction of scRNAseq methods and the computational tools allows to deconvolute developmental heterogeneity and draw a decomposed uniform map. In this manuscript, we decomposed the development of a human retina with a focus on the retinal ganglion cells (RGC). To increase the temporal resolution of retinal cell classes maturation state we assumed the working hypothesis that that maturation of retinal ganglion cells is a continuous, non-discrete process. We have assembled the scRNAseq atlas of human fetal retina from fetal week 8 to week 27 and applied the computational methods to unravel maturation heterogeneity into a uniform maturation track. We align RGC transcriptomes in pseudotime to map RGC developmental fate trajectories against the broader timeline of retinal development. Through this analysis, we identified the continuous maturation track of RGC and described the cell-intrinsic (DEGs, maturation gene profiles, regulons, transcriptional motifs) and -extrinsic profiles (neurotrophic receptors across maturation, cell-cell interactions) of different RGC maturation states. We described the genes involved in the retina and RGC maturation, including de novo RGC maturation drivers. We demonstrate the application of the human fetal retina atlas as a reference tool, allowing automated annotation and universal embedding of scRNAseq data. Altogether, our findings deepen the current knowledge of the retina and RGC maturation by bringing in the maturation dimension for the cell class vs. state analysis. We show how the pseudotime application contributes to developmental-oriented analyses, allowing to order the cells by their maturation state. This approach not only improves the downstream computational analysis but also provides a true maturation track transcriptomics profile.

bioinformatics↗

bioRxiv2024

Sustained neurotrophic factor cotreatment enhances donor and host retinal ganglion cell survival in mice

Retinal ganglion cells (RGCs) lack regenerative capacity in mammals, and their degeneration in glaucoma leads to irreversible blindness. Autologous and allogeneic RGC replacement with stem cell-derived neurons has been established as a promising strategy for vision restoration, but it has been limited by relatively low (<1%) survival rates of donor cells in the hostile microenvironment of a diseased retina and optic nerve. Brain-derived neurotrophic factor (BDNF) and glial-derived neurotrophic factor (GDNF) are known to support the survival of neurons, including RGCs in. vitro and in vivo. Here, we aim to improve donor RGC survival by supplementing our in vitro cultures and in transplants with a slow-release formulation of these neuroprotective agents. We show that slow-release BDNF/GDNF significantly enhances RGC differentiation, survival, and function in vitro. Furthermore, we demonstrated that BDNF/GDNF co-treatment improved mouse and human stem cell-derived donor RGC transplantation outcomes by 2.7- and 15-fold in mice, respectively. Lastly, we show that slow-release BDNF/GDNF provides neuroprotective effects on host RGCs, preserving retinal function in a model of optic neuropathy. Altogether, this approach of engineering the retinal microenvironment with slow-release neurotrophic factors significantly enhances both donor and host neuron survival, representing a promising approach for treating glaucoma and other optic neuropathies. Table of Contents Graphic O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=112 SRC="FIGDIR/small/583961v3_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@62d2eorg.highwire.dtl.DTLVardef@1805635org.highwire.dtl.DTLVardef@9bbea7org.highwire.dtl.DTLVardef@101e2f9_HPS_FORMAT_FIGEXP M_FIG C_FIG Engineering the retinal environment with neurotrophic factors to mimic development improves donor and host neuron survival, outgrowth, and function in an optic neuropathy mouse model.

bioengineering↗

bioRxiv2023

Suppressing DNMT3a Alleviates the Intrinsic Epigenetic Barrier for Optic Nerve Regeneration and Restores Vision in Adult Mice

The limited regenerative potential of the optic nerve in adult mammals presents a major challenge for restoring vision after optic nerve trauma or disease. The mechanisms of this regenerative failure are not fully understood1,2. Here, through small-molecule and genetic screening for epigenetic modulators3, we identify DNA methyltransferase 3a (DNMT3a) as a potent inhibitor of axon regeneration in mouse and human retinal explants. Selective suppression of DNMT3a in retinal ganglion cells (RGCs) by gene targeting or delivery of shRNA leads to robust, full-length regeneration of RGC axons through the optic nerve and restoration of vision in adult mice after nerve crush injury. Genome-wide bisulfite and transcriptome profiling in combination with single nucleus RNA-sequencing of RGCs revealed selective DNA demethylation and reactivation of genetic programs supporting neuronal survival and axonal growth/regeneration by DNMT3a deficiency. This was accompanied by the suppression of gene networks associated with apoptosis and inflammation. Our results identify DNMT3a as the central orchestrator of an RGC-intrinsic mechanism that limits optic nerve regeneration. Suppressing DNMT3a expression in RGCs unlocks the epigenetic switch for optic nerve regeneration and presents a promising therapeutic avenue for effectively reversing vision loss resulted from optic nerve trauma or diseases.

neuroscience↗

bioRxiv2022

Introduced chemokine gradients guide transplanted and regenerated retinal neurons toward their natural position in the retina

Ongoing cell replacement studies and clinical trials have demonstrated the need to control donor and newborn cell behavior within their target tissue. Here we present a methodology to guide stem cell-derived and endogenously regenerated neurons by engineering the microenvironment. Being an "approachable part of the brain," the eye provides a unique opportunity to study donor neuron fate, migration, and integration within the central nervous system. Glaucoma and other optic neuropathies lead to the permanent loss of retinal ganglion cells (RGCs) - the neurons in the retina that transfer all visual information from the eye to the brain. Cell transplantation and transdifferentiation strategies have been proposed to restore RGCs, and one of the significant barriers to successful RGC integration into the existing retinal circuitry is cell migration towards their natural position in the retina. Here we describe a framework for identifying, selecting, and applying chemokines to direct cell migration in vivo within the retina. We have performed an in silico analysis of the single-cell transcriptome of the developing human retina and identified six receptor-ligand candidates to guide stem cell-derived or newborn neurons. The lead candidates were then tested in functional in vitro assays for their ability to guide stem cell-derived RGCs. For the in vivo studies, donor and newborn neurons were differentiated in human and mouse retinal organoids or endogenously reprogrammed with proneuronal transcription factors, respectively. An exogenous stromal cell-derived factor-1 (SDF1) gradient led to a 2.7-fold increase in donor RGC migration into the ganglion cell layer and a 3.3-fold increase in the displacement of newborn RGCs out of the inner nuclear layer. Furthermore, by altering the migratory profile of donor RGCs toward multipolar migration, overall migration was improved in mature retinal tissues. Together, these results highlight the ability and importance of engineering the tissue microenvironment and the individual cells for research and clinical applications in gene and cell therapies. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=175 SRC="FIGDIR/small/510158v1_ufig1.gif" ALT="Figure 1"> View larger version (62K): org.highwire.dtl.DTLVardef@1856140org.highwire.dtl.DTLVardef@1b3ca26org.highwire.dtl.DTLVardef@9c9b34org.highwire.dtl.DTLVardef@19187c0_HPS_FORMAT_FIGEXP M_FIG C_FIG In brief, the "in silico - in vitro - in vivo" funnel holds significant potential for identifying targets to control cellular processes in research and clinical applications. In this report, Soucy et al. describes a framework for identifying, selecting, and applying chemokines to direct retinal ganglion cell migration in vivo within the adult mouse retina.

bioengineering↗